ET Capital

About The Fund

ET Capital, established in 1992 and based in Cambridge, United Kingdom, is a venture capital firm that specializes in early-stage investments. The firm targets high-growth companies in the IT, BioTech, CleanTech, Life Science, and TMT sectors. ET Capital pursues investments in innovative technology companies, particularly those that demonstrate an innovative application of technology. With an investment range of exactly 80 million GBP, they have a focus on early-stage ventures. ET Capital's investment strategy is centered around the globally significant clusters of science-based businesses around Cambridge, Oxford, and London. They began by managing two funds backed by HSBC and the European Investment Fund, which are now closed. Since 2004, they have been managing investments for Cambridge Research & Innovation Limited, an early-stage technology fund focused on the Cambridge cluster. Notably, one of their investments, ADC Therapeutics SA, went public on the New York Stock Exchange in May 2020 with a valuation of 1.3 billion USD.In 2018, ET Capital ventured into a partnership with UK China Enterprise LLP to create UK China Enterprise, an early-stage venture fund focused on science-based businesses with potential in China. They have also taken on the management of Carbon Order, investing in Carbon Engineering Limited, which was sold to Occidental Petroleum for 1.1 billion USD in August 2023.ET Capital's seventh and eighth funds, Carbon13 SEIS Fund I & II, are investing in businesses created by the Cambridge-based Carbon13 venture builder, aiming to have a significant impact on the climate emergency.The firm is actively managing investments in over 40 innovative technology businesses and has supported a series of entrepreneurs in building successful companies, with three becoming publicly-traded and eight achieving profitable exits. Their approach is tailored to support entrepreneurs in creating outstanding enterprises, and they remain a pivotal player in the venture capital landscape, facilitating the growth of promising companies and technologies.